Skip to main content

Table 2 Description of physician respondentsā€™ profiles and practice settings

From: Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network

Ā 

Pediatrician

Nā€‰=ā€‰3

IDS

Nā€‰=ā€‰19

Immunologist

Nā€‰=ā€‰23

On what qualification do you follow children with B or T cell deficiency?

Consultanta

0

14 (78%)

8 (35%)

Attending physicianb

1 (33%)

1 (5%)

1 (4%)

Both consultant and attending physician

2 (67%)

3 (17%)

14 (61%)

Did not answer

0

1

0

Where is your main practice located (Province/Territory)?

Alberta

0

0

1 (4%)

British Columbia

0

5 (26%)

6 (26%)

Manitoba

0

0

1 (4%)

Nova Scotia

0

0

2 (9%)

Newfoundland

0

0

3 (13%)

Ontario

0

2 (11%)

2 (9%)

Quebec

0

10 (53%)

8 (35%)

Saskatchewan

3 (100%)

2 (11%)

0

How many years have you been in practice?

0 to 4Ā years

0

2 (11%)

6 (27%)

5 to 9Ā years

2 (67%)

4 (22%)

4 (18%)

10 to 19Ā years

1 (33%)

5 (28%)

7 (32%)

20 to 29Ā years

0

4 (22%)

1 (5%)

ā€‰ā‰„ā€‰30Ā years

0

3 (17%)

4 (18%)

Did not answer

0

1

1

Which of the following best describes your practice setting?

Hospital-based

3 (100%)

19 (100%)

19 (83%)

Community-based

0

0

3 (13%)

Both academic and community hospital

0

0

1 (4%)

Is your practice setting university affiliated?

Yes

3 (100%)

19 (100%)

23 (100%)

No

0

0

0

In the past 12Ā months, how many patients with mild/moderate B cell deficiency did you see?

0

2 (67%)

2 (10%)

0

1ā€“5

1 (33%)

12 (60%)

6 (26%)

6ā€“10

0

3 (15%)

4 (17%)

ā€‰ā‰„ā€‰11

0

2 (10%)

13 (57%)

In the past 12Ā months, how many patients with mild/moderate T cell deficiency did you see?

0

1 (33%)

2 (10%)

1 (4%)

1ā€“5

1 (33%)

12 (60%)

5 (22%)

6ā€“10

1 (33%)

3 (15%)

6 (26%)

ā€‰ā‰„ā€‰11

0 (33%)

2 (10%)

11 (48%)

What information sources do you use to answer immunization-related questions? c

Provincial Immunization Guide

0

16 (84%)

16 (84%)

Canadian Immunization Guide

2 (67%)

13 (68%)

15 (65%)

Colleagues

2 (67%)

13 (68%)

12 (52%)

Red book

3 (100%)

12 (63%)

13 (68%)

CDC website

0

8 (42%)

11 (48%)

Other sources (number of physicians who mentioned the source) c, d

0

5 (26%)

4 (17%)

Total number of sources cited

ā‰¤ā€‰2 sources

2 (67%)

5 (26%)

9 (39%)

3ā€“4 sources

1 (33%)

6 (32%)

8 (35%)

ā€‰ā‰„ā€‰5 sources

0

8 (42%)

6 (26%)

In general, are vaccines administered to patients with mild/moderate B or T cell defects at your practice setting?

Yes

3 (100%)

15 (79%)

21 (91%)

No

0

3 (16%)

2 (9%)

Did not answer

0

1 (5%)

0

  1. ā€œMild/moderate primary B cell defectsā€: Clearly defined mild to moderate primary humoral defects (e.g. IgA deficiency, IgG subclass deficiency, specific antibody deficiency, transient hypogammaglobulinemia of infancy) and other unspecified or syndrome-related mild/moderate primary hypogammaglobulinemia (e.g. Down syndrome)
  2. ā€œMild/moderate combined defects (CID)ā€: Characterized by an incomplete reduction in T-cell number or activity where part of the immune systemā€™s ability to respond to infectious organisms is retained (e.g. partial DiGeorge syndrome, Ataxia Telangiectasia, Wiskott Aldrich syndrome, Purine Nucleoside Phosphorylase Deficiency)
  3. AAAAI American Academy of Allergy Asthma and Immunology, CDC Center for Disease Control and Prevention, CIS clinical immunology society, HIV human immunodeficiency virus, ID infectious disease, IDSA infectious diseases society of America, JACI journal of allergy and clinical immunology
  4. aConsultant: physician that gives a one-time opinion on the patientā€™s management
  5. bAttending physician: physician in charge of regular follow up
  6. cRespondents could give more than one response
  7. dOther sources: IDSA Guidelines, AAAAI Practice Parameters, Medline or articles, Journal of allergy and clinical immunology, primary literature, CIS Listservs and Immunology Conferences